PROKIDNEY CORP. (PROK)
Latest PROK Insider Trades
Brian Jg Pereira - DirectorOpen-market sale$314K- Brian Jg Pereira - DirectorOpen-market sale$38K
About PROKIDNEY CORP. (PROK)
ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its product candidate, REACT (Renal Autologous Cell Therapy), is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
- WINSTON-SALEM, NC
- 231
- 2022
- XNAS
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 6 | 757,164 | $1.07M |
| Grant or award | 1 | 750,000 | |
| Other acquisition / disposition | 9 | 2,763,063 |
PROK Insider Transactions (Form 4)
4125 Form 4 filings on record, the earliest from Apr 14, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Brian Jg Pereira - Director | Open-market sale | Class A Common Stock |
Recent PROK Form 8-K Filings
4Recent PROK Form 144 Notices of Proposed Sale
2A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Brian Pereira | Director | 81,929 | $114K | View on EDGAR | |
| Brian Pereira | Director |
PROK Insider Trading - FAQ
What is the latest insider trade for PROK?
PROKIDNEY CORP. (PROK) had 4 insider filings in the last 90 days, with the most recent on 2026-08-20. The full record for PROK runs to 25 Form 4 filings, the earliest from 2025-04-14. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying PROK stock?
No insider purchases of PROK were filed in the last 90 days. 7 purchases are on record for this company.
How many insiders are selling PROK stock?
6 insider sales of PROK were filed in the last 90 days, totaling $1.07M.
Where can I see PROK SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks PROK Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow PROK insider buys?
Create a free InsiderAlpha account and press Watch on this page to add PROK to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Brian Jg Pereira view on EDGAR
- - Brian Jg Pereira view on EDGAR
- - Kenneth Thomas Locke view on EDGAR
- - Todd C. Girolamo view on EDGAR
- - Alan Lotvin view on EDGAR
- - Santos Jose Ignacio Jimenez view on EDGAR
- - Jennifer A. Fox view on EDGAR
- - William F. Doyle view on EDGAR
- - Uma Sinha view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where PROK's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track PROK insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
